COMMUNIQUÉS West-GlobeNewswire

Reacta Healthcare Appoints Richard Nagle as Chair of Board of Directors
19/02/2026
Pharma, Biotech and Medtech Sector Leader and Entrepreneur to Drive Further Growth and Strategic Expansion DEESIDE, United Kingdom, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Reacta Healthcare Ltd, a leading developer of food [...]
Philips publishes its Annual Report 2025
19/02/2026
February 19, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the [...]
Q-Sera announces the first launch of blood collection tubes using its patented Rapclot technology in Japan, opening opportunities for additional global partnerships
19/02/2026
MELBOURNE, Australia , Feb. 19, 2026 (GLOBE NEWSWIRE) -- Q-Sera Pty Ltd, an Australian venture-backed company, today announced the first product launch of its patented evacuated blood collection technology, with the [...]
Ipsen S.A. publie ses comptes consolidés 2025
19/02/2026
Ipsen S.A. publie ses comptes consolidés 2025 Pièce jointe Ipsen_Comptes Consolidés 2025_FR
Valneva publie son chiffre d’affaires et sa trésorerie non audités pour l’exercice 2025 et fournit ses prévisions pour l’exercice 2026
19/02/2026
Chiffre d’affaires de 174,7millions d’euros en ligne avec les prévisions, dont 157,9 millions d’euros de ventes de vaccins Solide position de trésorerie de 109,7 millions d’euros à fin 2025 et flexibilité financière [...]
IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India
19/02/2026
Louvain-la-Neuve, Belgium – 19 February 2026 – IBA (Ion Beam Applications S.A., EURONEXT) , the world leader in particle accelerator technology with a preeminent position in nuclear medicine, and Shreeji (Shreeji [...]
BioVersys and Partners’ Phase 2a Tuberculosis Trial Results Published in New England Journal of Medicine
19/02/2026
Data from Phase 2a study demonstrated the first clinical proof of concept for alpibectir in combination with ethionamide (AlpE) in the treatment of patients with tuberculosis. The results, published in the prestigious [...]
IBA et Shreeji signent un accord pour quatre cyclotrons afin d’étendre la production de radiopharmaceutiques TEP en Inde
19/02/2026
Louvain-la-Neuve, Belgium – 19 février 2026 – IBA (Ion Beam Applications S.A., EURONEXT) , le leader mondial des technologies d'accélérateurs de particules et acteur de premier plan en médecine nucléaire, et Shreeji ( [...]
Zealand Pharma Announces Financial Results for the Full Year 2025
19/02/2026
Company announcement – No. 1 / 2026 Zealand Pharma Announces Financial Results for the Full Year 2025 2025 marked a quantum leap for Zealand Pharma, with a transformative partnership for petrelintide, strong clinical [...]
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
19/02/2026
February 19, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that [...]
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook
19/02/2026
Total Revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 million, with enhanced financial flexibility following successful debt [...]
Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants
19/02/2026
VICTORIA, British Columbia, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Rapid Nutrition PLC – Strategic Outlook and Near-Term Execution Update
19/02/2026
Well-capitalised HealthTech group enters delivery phase across platform expansion, selective acquisitions and science-led product development LONDON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC , a HealthTech [...]
ACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
18/02/2026
Study Confirms Long-Acting Treatment is Effective among People Living with HIV Who Experience Challenges Taking Daily Oral Treatment CHAPEL HILL, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials [...]
XOMA Royalty to Present at Investor Conferences in March
18/02/2026
EMERYVILLE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the following investor [...]
Precise Bio to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
18/02/2026
GREENSBORO, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Precise Bio, Inc. (“Precise Bio” or the “Company”), a clinical-stage regenerative medicine company pioneering bio-printed tissues and organs with an initial focus on [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/02/2026
FOSTER CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective February 17, 2026, it granted stock options to [...]
Amwell makes grant to new employee under inducement plan
18/02/2026
BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announced that on February 18, Amwell made a grant [...]
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
18/02/2026
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“ BriaCell ”), a clinical-stage biotechnology company that [...]

Pages